Explaining Price in a Multi-Price World: What TrumpRx and Populist Pressure Mean for Pharma
For more than two decades, the dominant paradigm for explaining pharmaceutical pricing has been value. That value was defined by clinical benefit, improved patient outcomes or experience, and the longer-term societal return of reducing disease burden. While value itself has not had a singular definition, it did provide a framework that shaped how therapies were launched, reimbursed, and defended — particularly for specialty and […]
Empowering the Partners Who Expand Access to Care
Access to quality health care is something we all want. We all benefit from medical progress, innovative care and new technologies that help people live healthier lives. When people are healthy, families, communities and societies thrive. And while we know our health care system has real strengths, we also know it can be stronger — because right now, not everyone is getting the care they need. We […]
No Prescription Needed: The Big Switch Toward Patient Empowerment
America’s medicine cabinet hasn’t kept pace with its health care needs. While digital tools and consumer empowerment have transformed nearly every facet of modern health care, prescription-to-over-the-counter (Rx-to-OTC) product switches have slowed to a crawl. The FDA wants to change that. Flipping the Switch — Again The FDA is pushing to expand consumer access to […]
Value Communications in a Constantly Shifting Policy Landscape
Policy has always influenced how the biopharmaceutical industry communicates the value of its medicines. However, today’s value communicators must be more agile than ever. In the past two weeks alone, the White House has made announcements on TrumpRX, pricing deals with Pfizer and AstraZeneca, and delayed pharmaceutical tariffs—and this doesn’t account for ongoing policy around […]
Measuring What Matters in the Scroll-and-Swipe Era
In today’s scroll-and-swipe culture, every personal device has effectively become an advertising platform. With audiences constantly exposed to an endless stream of messages and imagery, every campaign faces the same challenge: cutting through the clutter to drive recall, awareness, and action. Measuring What Truly Matters We all want our campaigns to make an impact […]
The New Architecture of Influence in Health Care
For decades, health policy debates in Washington were guided by a relatively stable set of inside-the-Beltway insiders: lobbyists, trade associations, think tanks, congressional staff, and government experts. Influence flowed primarily through these traditional channels, with institutional players acting as the gatekeepers of policy ideas and legislative outcomes. That dynamic has not disappeared. Traditional institutions remain […]
Your Fall Roadmap to Advancing Health Policy Before Year-End
Health policy activity is not expected to slow down this fall. Several milestones on the horizon will present both challenges and opportunities for healthcare stakeholders seeking to advance their priorities by year-end. Below is an overview of key issues to watch, their potential implications, and opportunities for engagement. Government Funding Deadline Looms Status: Congress […]
Crisis Management Shouldn’t Wait for a Crisis
The worst crisis an organization can confront is one it faces without preparation. It’s easy for a successful organization to be caught flat-footed by events—some truly unforeseen, others not yet fully anticipated. Such an unexpected event or issue can pull a company into crisis within hours. In these moments, how an organization reacts can substantially […]
From Communities to Capitols: The Power of State-Level Advocacy
In the current political landscape, where the federal agenda is evolving rapidly and many of the traditional advocacy channels are in flux, some of the most meaningful movement in health care policy is happening far from the Beltway — in statehouses, ballot boxes, and local communities across the country. For policymakers, trade associations, and national […]
Shaping Health Care Narratives in the New Frontier of AI Summaries
What Public Affairs Leaders Need to Know Public discourse on health care today is being shaped more and more by algorithms. As generative AI platforms – like ChatGPT, Claude and Perplexity – and new search engine tools like Google’s AI Overviews become trusted sources of information for the public, the way narratives form and evolve […]